ValueScreener

Medical - Instruments & Supplies stocks

Every US Medical - Instruments & Supplies company with filed annual reports: 50, in the Healthcare sector, with the ratios the screener prints. A name opens the company’s page, where every filed figure carries the filing it was read from and every price the day of its close.

Medians across Medical - Instruments & Supplies companies

Price to earnings
32.40x of 20
Price to book
2.92x of 46
Enterprise value to EBIT
28.67x of 17
Free cash flow yield
1.5% of 42
Return on invested capital, after tax
7.1% of 17
Debt to equity
0.52 of 29
Dividend yield
1.1% of 13

The companies

Medical - Instruments & Supplies: every company by market value, with its filed ratios
CompanyMarket capP/EP/BEV/EBITFCF yldROICD/EDiv yld
Intuitive Surgical, Inc. ISRG148.50B52.53x8.55xn/a1.6%n/an/an/a
Becton, Dickinson and Company BDX51.45B32.40x2.15x28.67x4.9%5.1%0.792.1%
ResMed Inc. RMD34.13B22.47x5.22x17.87x4.8%25.2%0.131.1%
Alcon Inc. ALC31.15B31.79x1.41x25.64x5.5%4.5%0.240.5%
Medline Inc. MDLN30.38Bn/m2.83x18.74x4.3%9.4%1.21n/a
West Pharmaceutical Services, Inc. WST26.37B54.85x8.58x45.77x1.7%17.2%0.100.2%
Baxter International Inc. BAX12.82Bn/m2.08xn/a2.6%n/a1.600.2%
The Cooper Companies, Inc. COO10.70B29.19x1.33x19.99x4.0%4.1%0.340.0%
Avantor, Inc. AVTR10.62Bn/m1.92xn/a4.6%n/a0.75n/a
Repligen Corporation RGEN10.06B204.83x4.78xn/a0.9%n/an/an/a
AptarGroup, Inc. ATR7.68B20.15x3.01x18.36x3.7%10.4%0.591.6%
Bausch + Lomb Corporation BLCO5.73Bn/m0.88x92.95x-1.2%n/a0.81n/a
Haemonetics Corporation HAE5.51B58.79x7.20x43.16x4.5%6.5%1.60n/a
Teleflex Incorporated TFX5.46Bn/m1.76x67.34x0.03%n/a0.911.1%
Stevanato Group S.p.A. STVN5.27B33.75x3.18xn/a0.5%n/an/a0.3%
Merit Medical Systems, Inc. MMSI5.20B40.17x3.33x30.56x4.1%7.1%0.52n/a
ICU Medical, Inc. ICUI4.07B5423.00x1.91x118.89x2.3%0.6%0.63n/a
Pulse Biosciences, Inc. PLSE3.21Bn/m38.70xn/a-1.7%n/a0.09n/a
Warby Parker Inc. WRBY3.06B2492.00x8.48xn/a1.4%-0.9%0.63n/a
AtriCure, Inc. ATRC2.92Bn/m5.56xn/a1.8%n/a0.16n/a
LeMaitre Vascular, Inc. LMAT1.89B32.40x4.81xn/a3.9%n/an/a1.1%
DENTSPLY SIRONA Inc. XRAY1.69Bn/m1.26xn/a6.2%n/a1.841.9%
Azenta, Inc. AZTA1.63Bn/m0.99xn/a2.2%n/an/an/a
NovoCure Limited NVCR1.61Bn/m4.53xn/a-4.9%n/an/an/a
KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS1.49Bn/m5.32xn/a-8.4%n/a0.18n/a
STAAR Surgical Company STAA1.09Bn/m3.15xn/a-3.7%n/an/an/a
QuidelOrtho Corporation QDEL945.8Mn/m0.49xn/a-8.8%n/a1.48n/a
AngioDynamics, Inc. ANGO456.7Mn/m2.69xn/a0.1%n/an/an/a
Sanara MedTech Inc. SMTI322.9Mn/m51.00xn/a0.7%n/an/an/a
InfuSystem Holdings, Inc. INFU270.9M42.50x5.01x25.74x8.3%9.6%0.40n/a
OraSure Technologies, Inc. OSUR255.4Mn/m0.80xn/a-19.5%n/an/an/a
Utah Medical Products, Inc. UTMD238.1M21.49x2.03x13.78x5.9%26.8%0.0041.7%
Pro-Dex, Inc. PDEX193.4M14.11x4.17xn/a3.4%n/an/an/a
Anbio Biotechnology Class A Ordinary Shares NNNN156.7M24.47x5.20x25.82xn/a25.8%n/an/a
KORU Medical Systems, Inc. KRMD142.9Mn/m8.43xn/a-0.3%n/an/an/a
Nyxoah S.A. NYXH125.1Mn/m2.28xn/a-62.3%n/an/an/a
Stereotaxis, Inc. STXS102.8Mn/m7.08xn/a-14.4%n/an/a0.0%
Precision Optics Corporation, Inc. POCI47.3Mn/m1.81xn/a-5.4%n/a0.20n/a
Microbot Medical Inc. MBOT45.2Mn/m0.59xn/a-28.9%n/a0.01n/a
Nephros, Inc. NEPH38.6M32.36x3.83x30.29xn/a19.4%0.10n/a
Harvard Bioscience, Inc. HBIO37.1Mn/mn/an/an/a-97.2%3.22n/a
Milestone Scientific Inc. MLSS30.7Mn/m9.88xn/a-10.6%n/an/an/a
Retractable Technologies, Inc. RVP17.8Mn/m0.24xn/a-42.8%n/an/an/a
Jin Medical International Ltd. ZJYL15.8M13.27x0.53x44.82x-23.6%1.3%0.64n/a
Regentis Biomaterials Ltd. RGNT10.6Mn/m2.24xn/an/an/m0.25n/a
Innovative Eyewear, Inc. LUCY5.3Mn/mn/an/an/mn/an/an/a
Femasys Inc. FEMY4.7Mn/mn/an/an/mn/an/an/a
WORK Medical Technology Group Ltd. WOK3.3Mn/m0.18xn/a151.0%n/a0.35n/a
GlucoTrack, Inc. GCTK708.2Kn/a0.01xn/an/mn/an/an/a
NEXGEL, Inc. NXGL115.7Kn/mn/an/an/an/an/an/a

Largest published market value first. No ratio orders this list, and a company whose market value is not published is listed last.

Prices as of 2026-10-14. Ratios recomputed from the filings 2026-10-14. Every ratio passes the same applicability gate as the screener and the research page, with the latest filed fiscal year's statements. A list is not a recommendation: see the limits of what this tool can tell you.

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map
  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.